(Q38461481)

English

Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design

scientific article published on 18 June 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Lawrence Richer

0 references

author name string

Eric Pearlman

2

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Donald Lewis

3

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Mirja Hämäläinen

4

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Kathryn Connor

5

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

David Michelson

6

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Ying Zhang

7

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Christopher Assaid

8

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Lyn Harper Mozley

9

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Nancy Strickler

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Robert Bachman

11

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Erin Mahoney

12

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Christopher Lines

13

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

David J Hewitt

14

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Rizatriptan Protocol 082 Pediatric Migraine Study Group

15

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

language of work or name

0 references

publication date

18 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

750-765

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

Migraine prevalence, disease burden, and the need for preventive therapy

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study.

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Children's ibuprofen suspension for the acute treatment of pediatric migraine

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

The placebo responder rate in children and adolescents

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

The placebo response in studies of acute migraine

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

A randomized trial of rizatriptan in migraine attacks in children

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Pharmacokinetic profile of rizatriptan 10-mg tablet and 10-mg orally disintegrating tablet administered with or without water in healthy subjects: an open-label, randomized, single-dose, 3-period crossover study

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Practice parameter: evaluation of children and adolescents with recurrent headaches: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society

1 reference

https://api.crossref.org/works/10.1177%2F0333102412451358

21 January 2018

Identifiers

10.1177/0333102412451358

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

release_osgajlhcxrgw3ig3zk6klfwevy

1 reference

https://api.fatcat.wiki/v0/release/osgajlhcxrgw3ig3zk6klfwevy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38461481&oldid=2147348212"